Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial

Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial

The Best Endovascular Versus Best Surgical Therapy in Patients With Chronic Limb-Threatening Ischemia trial was a landmark trial which provides high-quality data for the decision-making regarding the treatment of chronic-limb threatening ischemia. Overall, the trial suggests that in patients with ad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of vascular surgery 2024-10, Vol.107, p.93-100
Hauptverfasser: D'Angelo, Olivia, Menard, Matthew T., Farber, Alik
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue
container_start_page 93
container_title Annals of vascular surgery
container_volume 107
creator D'Angelo, Olivia
Menard, Matthew T.
Farber, Alik
description The Best Endovascular Versus Best Surgical Therapy in Patients With Chronic Limb-Threatening Ischemia trial was a landmark trial which provides high-quality data for the decision-making regarding the treatment of chronic-limb threatening ischemia. Overall, the trial suggests that in patients with adequate greater saphenous vein conduit, bypass surgery should be offered as a first line treatment given superior outcomes. In this article, we outline the common critiques of the trial, followed by responses to provide a deeper understanding of the strengths and limitations of this important trial.
doi_str_mv 10.1016/j.avsg.2023.12.100
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3037398874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0890509624001493</els_id><sourcerecordid>3037398874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-f8586edb316ad03416a431a1cd1213b6e0189814c51b08707add885721b166793</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi0EomnhD3BAPpbDBs96P7wSF7oKJVKkIrpwtbz2JOtoP4LtDepP4d_WUUqPPY0088yreecl5AOwJTAoPu-X6uh3y5SlfAlp7LFXZAEF5EleZeVrsmCiYknOquKCXHq_ZwxSkYm35IKLvIpItSD_6mkYppHWzgarrR88VaOhP7GdQ1C9p9OWhg7pDfpAV6OZjsrruVeO_kbnZ38e3M9uZ7XqadOhU4cHakf6QwWLY_D0rw0drTs3jVbTjR3apOkcqoCjHXd07XWHg1X0-mZ13yT1Zv2JNs6q_h15s40H4PunekV-fVs19fdkc3e7rr9uEs1ZGZKtyEWBpuVQKMN4FkvGQYE2kAJvC2QgKgGZzqFlomSlMkaIvEyhhaIoK35Frs-6Bzf9maMbOVivse_ViNPsJWe85JUQZRbR9IxqN3nvcCsPzg7KPUhg8hSJ3MtTJPIUiYQ09lhc-vikP7cDmueV_xlE4MsZwOjyaNFJr-PnNBrrUAdpJvuS_iOK55z7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037398874</pqid></control><display><type>article</type><title>Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial</title><source>Elsevier ScienceDirect Journals</source><creator>D'Angelo, Olivia ; Menard, Matthew T. ; Farber, Alik</creator><creatorcontrib>D'Angelo, Olivia ; Menard, Matthew T. ; Farber, Alik</creatorcontrib><description>The Best Endovascular Versus Best Surgical Therapy in Patients With Chronic Limb-Threatening Ischemia trial was a landmark trial which provides high-quality data for the decision-making regarding the treatment of chronic-limb threatening ischemia. Overall, the trial suggests that in patients with adequate greater saphenous vein conduit, bypass surgery should be offered as a first line treatment given superior outcomes. In this article, we outline the common critiques of the trial, followed by responses to provide a deeper understanding of the strengths and limitations of this important trial.</description><identifier>ISSN: 0890-5096</identifier><identifier>ISSN: 1615-5947</identifier><identifier>EISSN: 1615-5947</identifier><identifier>DOI: 10.1016/j.avsg.2023.12.100</identifier><identifier>PMID: 38599479</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><ispartof>Annals of vascular surgery, 2024-10, Vol.107, p.93-100</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-f8586edb316ad03416a431a1cd1213b6e0189814c51b08707add885721b166793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0890509624001493$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38599479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D'Angelo, Olivia</creatorcontrib><creatorcontrib>Menard, Matthew T.</creatorcontrib><creatorcontrib>Farber, Alik</creatorcontrib><title>Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial</title><title>Annals of vascular surgery</title><addtitle>Ann Vasc Surg</addtitle><description>The Best Endovascular Versus Best Surgical Therapy in Patients With Chronic Limb-Threatening Ischemia trial was a landmark trial which provides high-quality data for the decision-making regarding the treatment of chronic-limb threatening ischemia. Overall, the trial suggests that in patients with adequate greater saphenous vein conduit, bypass surgery should be offered as a first line treatment given superior outcomes. In this article, we outline the common critiques of the trial, followed by responses to provide a deeper understanding of the strengths and limitations of this important trial.</description><issn>0890-5096</issn><issn>1615-5947</issn><issn>1615-5947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU1vEzEQhi0EomnhD3BAPpbDBs96P7wSF7oKJVKkIrpwtbz2JOtoP4LtDepP4d_WUUqPPY0088yreecl5AOwJTAoPu-X6uh3y5SlfAlp7LFXZAEF5EleZeVrsmCiYknOquKCXHq_ZwxSkYm35IKLvIpItSD_6mkYppHWzgarrR88VaOhP7GdQ1C9p9OWhg7pDfpAV6OZjsrruVeO_kbnZ38e3M9uZ7XqadOhU4cHakf6QwWLY_D0rw0drTs3jVbTjR3apOkcqoCjHXd07XWHg1X0-mZ13yT1Zv2JNs6q_h15s40H4PunekV-fVs19fdkc3e7rr9uEs1ZGZKtyEWBpuVQKMN4FkvGQYE2kAJvC2QgKgGZzqFlomSlMkaIvEyhhaIoK35Frs-6Bzf9maMbOVivse_ViNPsJWe85JUQZRbR9IxqN3nvcCsPzg7KPUhg8hSJ3MtTJPIUiYQ09lhc-vikP7cDmueV_xlE4MsZwOjyaNFJr-PnNBrrUAdpJvuS_iOK55z7</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>D'Angelo, Olivia</creator><creator>Menard, Matthew T.</creator><creator>Farber, Alik</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241001</creationdate><title>Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial</title><author>D'Angelo, Olivia ; Menard, Matthew T. ; Farber, Alik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-f8586edb316ad03416a431a1cd1213b6e0189814c51b08707add885721b166793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>D'Angelo, Olivia</creatorcontrib><creatorcontrib>Menard, Matthew T.</creatorcontrib><creatorcontrib>Farber, Alik</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D'Angelo, Olivia</au><au>Menard, Matthew T.</au><au>Farber, Alik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial</atitle><jtitle>Annals of vascular surgery</jtitle><addtitle>Ann Vasc Surg</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>107</volume><spage>93</spage><epage>100</epage><pages>93-100</pages><issn>0890-5096</issn><issn>1615-5947</issn><eissn>1615-5947</eissn><abstract>The Best Endovascular Versus Best Surgical Therapy in Patients With Chronic Limb-Threatening Ischemia trial was a landmark trial which provides high-quality data for the decision-making regarding the treatment of chronic-limb threatening ischemia. Overall, the trial suggests that in patients with adequate greater saphenous vein conduit, bypass surgery should be offered as a first line treatment given superior outcomes. In this article, we outline the common critiques of the trial, followed by responses to provide a deeper understanding of the strengths and limitations of this important trial.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>38599479</pmid><doi>10.1016/j.avsg.2023.12.100</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0890-5096
ispartof Annals of vascular surgery, 2024-10, Vol.107, p.93-100
issn 0890-5096
1615-5947
1615-5947
language eng
recordid cdi_proquest_miscellaneous_3037398874
source Elsevier ScienceDirect Journals
title Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A39%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Common%20Criticisms%20and%20Rebuttals%20of%20the%20Best%20Endovascular%20Versus%20Best%20Surgical%20Therapy%20in%20Patients%20with%20Chronic%20Limb-Threatening%20Ischemia%20(BEST-CLI)%20Trial&rft.jtitle=Annals%20of%20vascular%20surgery&rft.au=D'Angelo,%20Olivia&rft.date=2024-10-01&rft.volume=107&rft.spage=93&rft.epage=100&rft.pages=93-100&rft.issn=0890-5096&rft.eissn=1615-5947&rft_id=info:doi/10.1016/j.avsg.2023.12.100&rft_dat=%3Cproquest_cross%3E3037398874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3037398874&rft_id=info:pmid/38599479&rft_els_id=S0890509624001493&rfr_iscdi=true